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Introduction
Noninvasive imaging of atherosclerosis may benefit from the characterization of plaque biological activity. Macrophages are ideal targets as they have a critical role in progression of atherosclerotic lesions. Novel graphite/metal core-shell nanocrystals (CN) show promising properties as MRI contrast agents for cellular imaging [1] .
Purpose
To evaluate 1) CN uptake by macrophages in vitro, and 2) CN uptake in mouse atherosclerotic lesions in vivo.
Methods
Graphite/Metal core-shell nanocrystals CN are composed of an Fe/Co core with a carbon graphite shell and phospholipid-polyethylene glycol molecules, with Cy5.5 attached for in vivo experiments.
In Vitro Uptake/Imaging
Mouse macrophage cells (RAW264) were incubated with ferumoxytol (Feridex), ferumoxtran-10 (Combidex), or graphite/metal core-shell nanocrystals (CN) for 24 hours, each at a concentration of 100 ugFe/ml. After incubation, 5 × 10 6 cells from each group were scanned by MRI at 1.5 T (GE Healthcare, Milwaukee, WI) to examine cellular uptake of contrast using a standard gradient echo sequence (TR/TE = 100/10, FA = 30, Matrix = 256 × 256, slice thickness = 2.0, FOV = 12 cm).
In Vivo Uptake/Imaging FVB mice (N = 5) underwent a carotid-ligation procedure previously shown to produce a macrophage-rich atherosclerotic lesion. Briefly, they were given high fat diet for 4 weeks and then had diabetes induced by 5 daily intraperitoneal injections of streptozotocin. After 2 weeks of diabetes, carotid ligation of the left carotid artery was performed. Two weeks post carotid ligation, mice were given CN-Cy5.5 (8 nmol of Cy5.5) via tail vein and scanned serially over 12-48 hours using the Maestro invivo fluorescent imaging system (CRI, Woburn, MA). After final in vivo imaging, carotid arteries were exposed and both in situ and ex vivo imaging were performed.
Results
In vitro CN uptake by macrophages was clearly seen by T2*-weighted MRI. The area of signal loss was significantly greater (p < 0.001, Figure 1 ) for CN than ferumoxtran-10 (Combidex; common in vivo macrophage imaging agent). However, the uptake of CN in vitro was less than ferumoxytol (Feridex; common in vitro stem cell labeling agent).
In vivo fluorescence imaging showed limited carotid signal, but both in situ and ex vivo fluorescence imaging at 12-48 hours showed high signal from the ligated left carotid, confirming in vivo CN uptake in the atherosclerotic lesions (Figure 2) . No evidence of CN accumulation was seen in the non-ligated right carotid arteries. Contrast uptake by macrophages (T2 weighted images) Figure 1 Contrast uptake by macrophages (T2 weighted images).
